vs
Side-by-side financial comparison of Orange County Bancorp, Inc. (OBT) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
Orange County Bancorp, Inc. is the larger business by last-quarter revenue ($33.0M vs $18.3M, roughly 1.8× ROCKWELL MEDICAL, INC.). Orange County Bancorp, Inc. runs the higher net margin — 37.6% vs -3.0%, a 40.7% gap on every dollar of revenue. On growth, Orange County Bancorp, Inc. posted the faster year-over-year revenue change (20.6% vs -25.6%). Orange County Bancorp, Inc. produced more free cash flow last quarter ($41.3M vs $2.2M). Over the past eight quarters, Orange County Bancorp, Inc.'s revenue compounded faster (14.3% CAGR vs -10.1%).
Orange County Bancorp, Inc. is a Delaware-registered bank holding company operating mainly in New York, U.S. It offers a full range of retail and commercial banking services, including deposit accounts, loans and wealth management solutions, serving individual consumers, small and mid-sized corporate clients in its regional footprint.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
OBT vs RMTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $33.0M | $18.3M |
| Net Profit | $12.4M | $-554.0K |
| Gross Margin | — | 21.1% |
| Operating Margin | 41.4% | -2.2% |
| Net Margin | 37.6% | -3.0% |
| Revenue YoY | 20.6% | -25.6% |
| Net Profit YoY | 73.5% | 26.7% |
| EPS (diluted) | $0.94 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $33.0M | $18.3M | ||
| Q3 25 | $33.7M | $15.9M | ||
| Q2 25 | $32.5M | $16.1M | ||
| Q1 25 | $28.0M | $18.9M | ||
| Q4 24 | $27.4M | $24.7M | ||
| Q3 24 | $27.1M | $28.3M | ||
| Q2 24 | $27.9M | $25.8M | ||
| Q1 24 | $25.3M | $22.7M |
| Q4 25 | $12.4M | $-554.0K | ||
| Q3 25 | $10.0M | $-1.8M | ||
| Q2 25 | $10.5M | $-1.5M | ||
| Q1 25 | $8.7M | $-1.5M | ||
| Q4 24 | $7.2M | $-756.0K | ||
| Q3 24 | $3.2M | $1.7M | ||
| Q2 24 | $8.2M | $343.0K | ||
| Q1 24 | $9.3M | $-1.7M |
| Q4 25 | — | 21.1% | ||
| Q3 25 | — | 14.3% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | — | 16.1% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 22.0% | ||
| Q2 24 | — | 17.6% | ||
| Q1 24 | — | 13.5% |
| Q4 25 | 41.4% | -2.2% | ||
| Q3 25 | 38.6% | -9.9% | ||
| Q2 25 | 41.9% | -8.4% | ||
| Q1 25 | 40.3% | -7.2% | ||
| Q4 24 | 32.8% | -2.1% | ||
| Q3 24 | 14.8% | 6.8% | ||
| Q2 24 | 36.6% | 2.0% | ||
| Q1 24 | 45.9% | -5.8% |
| Q4 25 | 37.6% | -3.0% | ||
| Q3 25 | 29.7% | -11.0% | ||
| Q2 25 | 32.2% | -9.3% | ||
| Q1 25 | 31.1% | -8.0% | ||
| Q4 24 | 26.2% | -3.1% | ||
| Q3 24 | 11.8% | 5.9% | ||
| Q2 24 | 29.4% | 1.3% | ||
| Q1 24 | 36.7% | -7.6% |
| Q4 25 | $0.94 | $-0.01 | ||
| Q3 25 | $0.75 | $-0.05 | ||
| Q2 25 | $0.87 | $-0.05 | ||
| Q1 25 | $0.77 | $-0.04 | ||
| Q4 24 | $0.64 | $-0.02 | ||
| Q3 24 | $0.28 | $0.04 | ||
| Q2 24 | $0.73 | $0.01 | ||
| Q1 24 | $0.82 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $10.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $284.4M | $37.0M |
| Total Assets | $2.7B | $57.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $10.7M | ||
| Q3 25 | — | $13.6M | ||
| Q2 25 | — | $12.5M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | — | $15.7M | ||
| Q3 24 | — | $12.3M | ||
| Q2 24 | — | $11.9M | ||
| Q1 24 | — | $6.6M |
| Q4 25 | $284.4M | $37.0M | ||
| Q3 25 | $270.1M | $37.0M | ||
| Q2 25 | $252.6M | $30.4M | ||
| Q1 25 | $201.3M | $31.5M | ||
| Q4 24 | $185.5M | $32.6M | ||
| Q3 24 | $193.1M | $29.1M | ||
| Q2 24 | $177.5M | $23.5M | ||
| Q1 24 | $168.7M | $20.6M |
| Q4 25 | $2.7B | $57.1M | ||
| Q3 25 | $2.6B | $57.5M | ||
| Q2 25 | $2.6B | $52.6M | ||
| Q1 25 | $2.6B | $54.0M | ||
| Q4 24 | $2.5B | $59.2M | ||
| Q3 24 | $2.5B | $57.1M | ||
| Q2 24 | $2.5B | $53.0M | ||
| Q1 24 | $2.5B | $50.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $43.8M | $2.3M |
| Free Cash FlowOCF − Capex | $41.3M | $2.2M |
| FCF MarginFCF / Revenue | 125.1% | 12.0% |
| Capex IntensityCapex / Revenue | 7.6% | 0.5% |
| Cash ConversionOCF / Net Profit | 3.53× | — |
| TTM Free Cash FlowTrailing 4 quarters | $69.6M | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $43.8M | $2.3M | ||
| Q3 25 | $30.2M | $-1.3M | ||
| Q2 25 | $-5.0M | $1.8M | ||
| Q1 25 | $4.8M | $-3.5M | ||
| Q4 24 | $34.6M | $865.0K | ||
| Q3 24 | $10.2M | $4.3M | ||
| Q2 24 | $9.3M | $1.4M | ||
| Q1 24 | $2.3M | $-2.4M |
| Q4 25 | $41.3M | $2.2M | ||
| Q3 25 | $29.6M | $-1.5M | ||
| Q2 25 | $-5.7M | $1.7M | ||
| Q1 25 | $4.3M | $-3.5M | ||
| Q4 24 | $32.9M | $470.0K | ||
| Q3 24 | $10.0M | $4.1M | ||
| Q2 24 | $9.2M | $1.2M | ||
| Q1 24 | $2.0M | $-2.5M |
| Q4 25 | 125.1% | 12.0% | ||
| Q3 25 | 87.8% | -9.6% | ||
| Q2 25 | -17.5% | 10.5% | ||
| Q1 25 | 15.5% | -18.8% | ||
| Q4 24 | 120.0% | 1.9% | ||
| Q3 24 | 36.7% | 14.4% | ||
| Q2 24 | 32.8% | 4.5% | ||
| Q1 24 | 7.9% | -11.1% |
| Q4 25 | 7.6% | 0.5% | ||
| Q3 25 | 1.8% | 1.4% | ||
| Q2 25 | 2.3% | 1.0% | ||
| Q1 25 | 1.8% | 0.3% | ||
| Q4 24 | 6.3% | 1.6% | ||
| Q3 24 | 1.1% | 0.7% | ||
| Q2 24 | 0.4% | 1.1% | ||
| Q1 24 | 1.0% | 0.6% |
| Q4 25 | 3.53× | — | ||
| Q3 25 | 3.01× | — | ||
| Q2 25 | -0.47× | — | ||
| Q1 25 | 0.56× | — | ||
| Q4 24 | 4.83× | — | ||
| Q3 24 | 3.19× | 2.57× | ||
| Q2 24 | 1.13× | 4.20× | ||
| Q1 24 | 0.24× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OBT
Segment breakdown not available.
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
